$0.8026
-0.01-1.82%
Pre-Market: 5:55 PM EDT
Comments
Loading...
Spero Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SPRO | Benzinga
Spero Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 27
EPS Estimate
$-0.310
Quarterly Revenue Estimate
$6.20M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$89.86M
Analyze the earnings history of Spero Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics | -$0.24 | -$0.26 | — | — | $9.27M | $11.00M | — | — | 05/14/2025 | Get Alert |
| SPRO | Spero Therapeutics | $0.96 | -$0.31 | — | — | $73.52M | $6.20M | — | — | 03/27/2025 | Get Alert |
| SPRO | Spero Therapeutics | -$0.06 | -$0.36 | -$0.32 | 11.11% | $25.47M | $7.67M | $13.47M | 75.61% | 11/14/2024 | Get Alert |
| SPRO | Spero Therapeutics | -$0.23 | -$0.38 | -$0.33 | 13.16% | $2.72M | $3.27M | $10.20M | 211.83% | 08/05/2024 | Get Alert |
| SPRO | Spero Therapeutics | -$0.25 | -$0.04 | -$0.24 | -500.00% | $2.07M | $21.53M | $9.27M | -56.96% | 05/15/2024 | Get Alert |
| SPRO | Spero Therapeutics | $0.55 | -$0.10 | $0.96 | 1060.00% | $47.44M | $18.63M | $73.52M | 294.65% | 03/13/2024 | Get Alert |
| SPRO | Spero Therapeutics | -$0.33 | -$0.03 | -$0.06 | -100.00% | $2.01M | $14.97M | $25.47M | 70.16% | 11/13/2023 | Get Alert |
| SPRO | Spero Therapeutics | -$0.51 | -$0.34 | -$0.23 | 32.35% | $1.99M | $1.07M | $2.72M | 153.83% | 08/10/2023 | Get Alert |
| SPRO | Spero Therapeutics | -$1.01 | -$0.33 | -$0.25 | 24.24% | $2.07M | $1.00M | $2.07M | 106.90% | 05/11/2023 | Get Alert |
| SPRO | Spero Therapeutics | -$0.90 | $0.04 | $0.55 | 1275.00% | $2.74M | $22.87M | $47.44M | 107.44% | 03/30/2023 | Get Alert |
| SPRO | Spero Therapeutics | -$0.70 | -$0.30 | -$0.33 | -10.00% | $3.06M | $5.42M | $2.01M | -62.99% | 11/14/2022 | Get Alert |
| SPRO | Spero Therapeutics | -$0.63 | -$0.54 | -$0.51 | 5.56% | $5.15M | $1.15M | $1.99M | 73.30% | 08/10/2022 | Get Alert |
| SPRO | Spero Therapeutics | -$0.66 | -$0.87 | -$1.01 | -16.09% | $7.30M | $2.57M | $2.07M | -19.49% | 05/16/2022 | Get Alert |
| SPRO | Spero Therapeutics | -$0.68 | -$0.75 | -$0.90 | -20.00% | $1.91M | $4.95M | $2.74M | -44.57% | 03/31/2022 | Get Alert |
| SPRO | Spero Therapeutics | -$0.86 | -$0.66 | -$0.70 | -6.06% | $4.00M | $4.47M | $3.06M | -31.45% | 11/10/2021 | Get Alert |
| SPRO | Spero Therapeutics | -$0.85 | -$0.77 | -$0.63 | 18.18% | $1.73M | $4.03M | $5.15M | 27.74% | 08/05/2021 | Get Alert |
| SPRO | Spero Therapeutics | -$1.22 | -$0.64 | -$0.66 | -3.12% | $1.70M | $3.16M | $7.30M | 131.01% | 05/06/2021 | Get Alert |
| SPRO | Spero Therapeutics | -$1.32 | -$0.74 | -$0.68 | 8.11% | $3.63M | $3.67M | $1.91M | -48.04% | 03/11/2021 | Get Alert |
| SPRO | Spero Therapeutics | -$0.95 | -$0.87 | -$0.86 | 1.15% | $4.64M | $3.20M | $4.00M | 24.84% | 11/05/2020 | Get Alert |
| SPRO | Spero Therapeutics | -$0.74 | -$1.12 | -$0.85 | 24.11% | $2.16M | $3.40M | $1.73M | -49.21% | 08/06/2020 | Get Alert |
| SPRO | Spero Therapeutics | -$0.29 | -$1.25 | -$1.22 | 2.40% | $7.72M | $3.44M | $1.70M | -50.55% | 05/08/2020 | Get Alert |
Spero Therapeutics (SPRO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.32 | $-0.36 | 11.1 % |
| Q2 | 2024-08-05 | $-0.33 | $-0.38 | 13.2 % |
| Q1 | 2024-05-15 | $-0.24 | $-0.04 | -500.0 % |
| Q4 | 2024-03-13 | $0.96 | $-0.10 | 1060.0 % |
Spero Therapeutics (SPRO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $13.47M | $7.67M | 75.6 % |
| Q2 | 2024-08-05 | $10.20M | $3.27M | 211.8 % |
| Q1 | 2024-05-15 | $9.27M | $21.53M | -57.0 % |
| Q4 | 2024-03-13 | $73.52M | $18.63M | 294.6 % |
FAQ
When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?
Spero Therapeutics (SPRO) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Spero Therapeutics (NASDAQ:SPRO)?
The Actual EPS was $-0.32, which beat the estimate of $-0.36.
What were Spero Therapeutics’s (NASDAQ:SPRO) revenues?
The Actual Revenue was $13.5M, which beat the estimate of $7.7M.
Browse earnings estimates, EPS, and revenue on all stocks.